{"id":1984,"date":"2020-09-24T01:05:03","date_gmt":"2020-09-24T01:05:03","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=1984"},"modified":"2023-08-29T17:47:03","modified_gmt":"2023-08-29T17:47:03","slug":"incannex-ethics-approval-cannabinoid-phase-2b-clinical-trial-obstructive-sleep-apnoea","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=1984","title":{"rendered":"Incannex\u57282b\u671f\u963b\u585e\u6027\u7761\u7720\u547c\u5438\u6682\u505c\u8bd5\u9a8c\u4e2d\u7684\u65b0\u578b\u5927\u9ebb\u7d20\u83b7\u5f97\u4f26\u7406\u6279\u51c6"},"content":{"rendered":"<p><a href=\"http:\/\/smallcaps-production.test\/stocks\/?symbol=IHL&amp;lang=cn\">Incannex Healthcare (ASX: IHL)<\/a>\u5bf9\u5176\u5148\u5bfc\u836f\u7269IHL- 42x\u6cbb\u7597\u963b\u585e\u6027\u7761\u7720\u547c\u5438\u6682\u505c(OSA)\u60a3\u8005\u76842b\u671f\u4e34\u5e8a\u8bd5\u9a8c\u5df2\u83b7\u5f97\u4f26\u7406\u6279\u51c6\u3002<\/p>\n<p>\u8fd9\u662f\u8be5\u516c\u53f8\u4e0eSud Agarwal\u535a\u58eb\u548c\u58a8\u5c14\u672c\u4e00\u4f4d\u8457\u540d\u7684\u7761\u7720\u4e13\u5bb6\u5171\u540c\u5f00\u53d1\u7684\u4e13\u5229\u4fdd\u62a4\u7684IHL-42X\u52a0\u901f\u8ba1\u5212\u4e2d\u7684\u7b2c\u4e00\u4e2aFDA\u65b0\u836f\u7533\u8bf7\u8bd5\u9a8c\u3002<\/p>\n<p>\u8fd9\u9879\u968f\u673a\u3001\u53cc\u76f2\u3001\u5b89\u6170\u5242\u5bf9\u7167\u8bd5\u9a8c\u5c06\u5728\u58a8\u5c14\u672c\u7684\u963f\u5c14\u5f17\u96f7\u5fb7\u533b\u9662\u8fdb\u884c\uff0c\u4e3b\u8981\u7ec8\u70b9\u662f\u964d\u4f4e\u547c\u5438\u6682\u505c\u4f4e\u901a\u6c14\u6307\u6570(AHI)\uff0c\u8be5\u6307\u6570\u6d4b\u91cf\u7761\u7720\u671f\u95f4\u7684\u547c\u5438\u6682\u505c\u4e8b\u4ef6\u3002<\/p>\n<p>\u8be5\u8bd5\u9a8c\u88ab\u5f52\u7c7b\u4e3a\u4ea4\u53c9\u7814\u7a76\uff0c\u8fd9\u610f\u5473\u7740\u53c2\u4e0e\u8005\u5c06\u5728\u56db\u4e2a\u4e3a\u671f\u4e00\u5468\u7684\u7597\u7a0b\u4e2d\u63a5\u53d7\u4e09\u79cd\u4e0d\u540c\u7684\u53e3\u670d\u836f\u7269\u548c\u4e00\u79cd\u5b89\u6170\u5242\uff0c\u6bcf\u4e00\u4e2a\u7597\u7a0b\u95f4\u9694\u4e00\u5468\u7684\u201c\u51b2\u5237\u671f\u201d\uff0c\u4ee5\u4f7f\u836f\u7269\u5b8c\u5168\u4ece\u7cfb\u7edf\u4e2d\u6e05\u9664\u3002<\/p>\n<p>\u5728\u6bcf\u4e2a\u6cbb\u7597\u671f\u7684\u6700\u540e\u4e00\u665a\uff0c\u60a3\u8005\u5c06\u524d\u5f80\u533b\u9662\u7684\u7761\u7720\u8bca\u6240\uff0c\u901a\u8fc7\u901a\u5bb5\u591a\u5bfc\u7761\u7720\u63cf\u8bb0\u4eea\u786e\u5b9a\u4ed6\u4eec\u7684AHI\u3002\u591a\u5bfc\u7761\u7720\u63cf\u8bb0\u4eea\u662f\u4e00\u79cd\u8bca\u65ad\u5de5\u5177\uff0c\u53ef\u4ee5\u8bb0\u5f55\u60a3\u8005\u5728\u7761\u7720\u65f6\u7684\u8111\u7535\u6ce2\u3001\u8840\u6c27\u6c34\u5e73\u3001\u5fc3\u7387\u548c\u547c\u5438\uff0c\u4ee5\u53ca\u773c\u775b\u548c\u817f\u90e8\u7684\u8fd0\u52a8\u3002<\/p>\n<p>\u4f5c\u4e3a\u6b21\u8981\u7ec8\u70b9\uff0c\u53c2\u4e0e\u8005\u8fd8\u5c06\u8bc4\u4f30\u8b66\u89c9\u6027\u3001\u65e5\u95f4\u55dc\u7761\u3001\u60c5\u7eea\u548c\u751f\u6d3b\u8d28\u91cf\u7684\u6539\u5584\u60c5\u51b5<\/p>\n<h2>\u9ad8\u6d41\u884c\u75be\u75c5<\/h2>\n<p>OSA\u662f\u4e00\u79cd\u975e\u5e38\u666e\u904d\u7684\u75be\u75c5\uff0c\u4ec5\u5728\u7f8e\u56fd\u5c31\u6709\u5927\u7ea63000\u4e07\u6210\u5e74\u4eba\u60a3\u6709\u8fd9\u79cd\u75be\u75c5\u3002\u5c3d\u7ba1\u6bcf\u5929\u90fd\u611f\u5230\u4e0d\u8212\u670d\uff0c\u4f46\u5b83\u663e\u8457\u589e\u52a0\u4e86\u4e25\u91cd\u5065\u5eb7\u5e76\u53d1\u75c7\u7684\u53ef\u80fd\u6027\uff0c\u5982\u5fc3\u8840\u7ba1\u75be\u75c5\u3001\u9ad8\u8840\u538b\u3001\u4e2d\u98ce\u3001\u7cbe\u795e\u75be\u75c5\u751a\u81f3\u7cd6\u5c3f\u75c5\u3002<\/p>\n<p>\u672a\u786e\u8bca\u7684\u7761\u7720\u547c\u5438\u6682\u505c\u6bcf\u5e74\u7ed9\u7f8e\u56fd\u4eba\u53e3\u9020\u6210\u7684\u7ecf\u6d4e\u8d1f\u62c5\u7ea6\u4e3a1496\u4ebf\u7f8e\u5143\uff0c\u5176\u4e2d\u751f\u4ea7\u529b\u635f\u5931\u4e3a869\u4ebf\u7f8e\u5143\uff0c\u673a\u52a8\u8f66\u4e8b\u6545\u4e3a262\u4ebf\u7f8e\u5143\uff0c\u5de5\u4f5c\u573a\u6240\u4e8b\u6545\u4e3a65\u4ebf\u7f8e\u5143\u3002<\/p>\n<p>\u5728\u6fb3\u5927\u5229\u4e9a\uff0cDeloitte Access Economics\u4f30\u8ba1\uff0cOSA\u6bcf\u5e74\u9020\u6210\u7684\u76f4\u63a5\u7ecf\u6d4e\u6210\u672c\u8d85\u8fc7210\u4ebf\u6fb3\u5143\u3002<\/p>\n<h2>\u5e02\u573a\u673a\u4f1a<\/h2>\n<p>\u76ee\u524d\u9488\u5bf9OSA\u60a3\u8005\u7684\u6807\u51c6\u6cbb\u7597\u9009\u62e9\u662f\u673a\u68b0CPAP(\u6301\u7eed\u6c14\u9053\u6b63\u538b)\u88c5\u7f6e\u3002\u7136\u800c\uff0c\u7531\u4e8e\u5728\u7761\u7720\u65f6\u5c06\u52a0\u538b\u7a7a\u6c14\u5438\u5165\u53e3\u8154\uff0c\u665a\u4e0a\u6234\u4e0a\u53e3\u7f69\u5c06\u5176\u9001\u5165\u53e3\u8154\uff0c\u4ece\u800c\u5bfc\u81f4\u4e0d\u9002\u548c\u5e7d\u95ed\u6050\u60e7\u75c7\uff0c\u56e0\u6b64\u60a3\u8005\u7684\u957f\u671f\u4f9d\u4ece\u6027\u975e\u5e38\u4f4e\u3002<\/p>\n<p>Incannex\u6267\u884c\u8463\u4e8bJoel Latham\u8868\u793a\uff0c\u7531\u4e8e\u76ee\u524d\u5c1a\u65e0\u6ce8\u518c\u7684\u836f\u7269\u6cbb\u7597\uff0cIHL-42X\u5b58\u5728\u5de8\u5927\u7684\u5e02\u573a\u673a\u4f1a\u3002<\/p>\n<p>\u4ed6\u8bf4:\u201c\u4e00\u79cd\u6210\u529f\u7684\u836f\u7269\u6cbb\u7597\u5c06\u662f\u963b\u585e\u6027\u7761\u7720\u547c\u5438\u6682\u505c\u7684\u5178\u8303\u8f6c\u53d8\uff0c\u4e5f\u662f\u5411\u4e0d\u80fd\u8010\u53d7CPAP\u88c5\u7f6e\u7684\u60a3\u8005\u7684\u6b63\u786e\u65b9\u5411\u8fc8\u51fa\u7684\u91cd\u8981\u4e00\u6b65\u3002\u201d<\/p>\n<p>\u201c\u6211\u4eec\u671f\u671b\u80fd\u6781\u5927\u5730\u6539\u5584\u60a3\u8005\u7684\u6cbb\u7597\u4f9d\u4ece\u6027\u548c\u836f\u7269\u4ea7\u54c1\u7684\u6548\u679c\uff0c\u5982\u679c\u4e34\u5e8a\u8bc4\u4f30\u6210\u529f\u7684\u8bdd\uff0c\u8fd9\u53ef\u80fd\u662fIHL-42X\u3002\u201d<\/p>\n<h2>\u65b0\u4efb\u547d<\/h2>\n<p>\u540c\u65f6\uff0c\u5728\u672c\u5468\u7684\u5468\u4e8c\uff0cIncannex\u5ba3\u5e03\u4efb\u547dPaul Liknaitzky\u535a\u58eb\u4e3a\u5176\u533b\u5b66\u987e\u95ee\u59d4\u5458\u4f1a\u7684\u79d1\u5b66\u5b98\u5458\uff0c\u4efb\u671f\u81f3\u5c11\u4e3a18\u4e2a\u6708\uff0c\u6709\u4e13\u6709\u6743\u3002<\/p>\n<p>\u4ed6\u5c06\u4e3a\u65b0\u578b\u7cbe\u795e\u5236\u5242\u548c\u76f8\u5173\u7597\u6cd5\u7684\u7814\u7a76\u63d0\u4f9b\u5efa\u8bae\uff0c\u8fd9\u4e9b\u5236\u5242\u548c\u7597\u6cd5\u53ef\u80fd\u9002\u7528\u4e8e\u7126\u8651\u75c7\u548c\u6291\u90c1\u75c7\u76f8\u5173\u75be\u75c5\u7684\u6cbb\u7597\u3002<\/p>\n<p>\u73b0\u6709\u7684\u6cbb\u7597\u7126\u8651\u548c\u6291\u90c1\u7684\u836f\u7269\u9009\u62e9\u88ab\u8ba4\u4e3a\u6ca1\u6709\u8db3\u591f\u7684\u53cd\u5e94\u7387\u548c\u76f8\u5173\u7684\u4e0d\u826f\u526f\u4f5c\u7528\u3002<\/p>\n<p>Liknaitzky\u535a\u58eb\u5728\u58a8\u5c14\u672c\u5927\u5b66\u83b7\u5f97\u4e86\u795e\u7ecf\u79d1\u5b66\u8363\u8a89\u548c\u5fc3\u7406\u5b66\u535a\u58eb\u5b66\u4f4d\u3002\u4ed6\u7684\u5de5\u4f5c\u4e3b\u8981\u5728\u6291\u90c1\u3001\u7126\u8651\u548c\u6210\u763e\u7814\u7a76\u4e2d\u68c0\u67e5\u7cbe\u795e\u75be\u75c5\u7684\u673a\u5236\u548c\u6cbb\u7597\u53d1\u5c55\u3002<\/p>\n<p>\u4ed6\u5728\u58a8\u5c14\u672c\u7684\u5723\u6587\u68ee\u7279\u533b\u9662\u548c\u5176\u4ed6\u673a\u6784\u4efb\u804c\uff0c\u53c2\u4e0e\u4e86\u8ff7\u5e7b\u836f\u8fd9\u4e00\u65b0\u5174\u9886\u57df\u7684\u7814\u7a76\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Incannex Healthcare (ASX: IHL)\u5bf9\u5176\u5148\u5bfc\u836f\u7269IHL- 42x\u6cbb\u7597\u963b\u585e\u6027\u7761\u7720\u547c\u5438\u6682\u505c(OSA)\u60a3\u8005\u76842b\u671f\u4e34\u5e8a\u8bd5\u9a8c\u5df2\u83b7\u5f97\u4f26\u7406\u6279\u51c6\u3002 \u8fd9\u662f\u8be5\u516c\u53f8\u4e0eSud Agarwal\u535a\u58eb\u548c\u58a8\u5c14\u672c\u4e00\u4f4d\u8457\u540d\u7684\u7761\u7720\u4e13\u5bb6\u5171\u540c\u5f00\u53d1\u7684\u4e13\u5229\u4fdd\u62a4\u7684IHL-42X\u52a0\u901f\u8ba1\u5212\u4e2d\u7684\u7b2c\u4e00\u4e2aFDA\u65b0\u836f\u7533\u8bf7\u8bd5\u9a8c\u3002 \u8fd9\u9879\u968f\u673a\u3001\u53cc\u76f2\u3001\u5b89\u6170\u5242\u5bf9\u7167\u8bd5\u9a8c\u5c06\u5728\u58a8\u5c14\u672c\u7684\u963f\u5c14\u5f17\u96f7\u5fb7\u533b\u9662\u8fdb\u884c\uff0c\u4e3b\u8981\u7ec8\u70b9\u662f\u964d\u4f4e\u547c\u5438\u6682\u505c\u4f4e\u901a\u6c14\u6307\u6570(AHI)\uff0c\u8be5\u6307\u6570\u6d4b\u91cf\u7761\u7720\u671f\u95f4\u7684\u547c\u5438\u6682\u505c\u4e8b\u4ef6\u3002 \u8be5\u8bd5\u9a8c\u88ab\u5f52\u7c7b\u4e3a\u4ea4\u53c9\u7814\u7a76\uff0c\u8fd9\u610f\u5473\u7740\u53c2\u4e0e\u8005\u5c06\u5728\u56db\u4e2a\u4e3a\u671f\u4e00\u5468\u7684\u7597\u7a0b\u4e2d\u63a5\u53d7\u4e09\u79cd\u4e0d\u540c\u7684\u53e3\u670d\u836f\u7269\u548c\u4e00\u79cd\u5b89\u6170\u5242\uff0c\u6bcf\u4e00\u4e2a\u7597\u7a0b\u95f4\u9694\u4e00\u5468\u7684\u201c\u51b2\u5237\u671f\u201d\uff0c\u4ee5\u4f7f\u836f\u7269\u5b8c\u5168\u4ece\u7cfb\u7edf\u4e2d\u6e05\u9664\u3002 \u5728\u6bcf\u4e2a\u6cbb\u7597\u671f\u7684\u6700\u540e\u4e00\u665a\uff0c\u60a3\u8005\u5c06\u524d\u5f80\u533b\u9662\u7684\u7761\u7720\u8bca\u6240\uff0c\u901a\u8fc7\u901a\u5bb5\u591a\u5bfc\u7761\u7720\u63cf\u8bb0\u4eea\u786e\u5b9a\u4ed6\u4eec\u7684AHI\u3002\u591a\u5bfc\u7761\u7720\u63cf\u8bb0\u4eea\u662f\u4e00\u79cd\u8bca\u65ad\u5de5\u5177\uff0c\u53ef\u4ee5\u8bb0\u5f55\u60a3\u8005\u5728\u7761\u7720\u65f6\u7684\u8111\u7535\u6ce2\u3001\u8840\u6c27\u6c34\u5e73\u3001\u5fc3\u7387\u548c\u547c\u5438\uff0c\u4ee5\u53ca\u773c\u775b\u548c\u817f\u90e8\u7684\u8fd0\u52a8\u3002 \u4f5c\u4e3a\u6b21\u8981\u7ec8\u70b9\uff0c\u53c2\u4e0e\u8005\u8fd8\u5c06\u8bc4\u4f30\u8b66\u89c9\u6027\u3001\u65e5\u95f4\u55dc\u7761\u3001\u60c5\u7eea\u548c\u751f\u6d3b\u8d28\u91cf\u7684\u6539\u5584\u60c5\u51b5 \u9ad8\u6d41\u884c\u75be\u75c5 OSA\u662f\u4e00\u79cd\u975e\u5e38\u666e\u904d\u7684\u75be\u75c5\uff0c\u4ec5\u5728\u7f8e\u56fd\u5c31\u6709\u5927\u7ea63000\u4e07\u6210\u5e74\u4eba\u60a3\u6709\u8fd9\u79cd\u75be\u75c5\u3002\u5c3d\u7ba1\u6bcf\u5929\u90fd\u611f\u5230\u4e0d\u8212\u670d\uff0c\u4f46\u5b83\u663e\u8457\u589e\u52a0\u4e86\u4e25\u91cd\u5065\u5eb7\u5e76\u53d1\u75c7\u7684\u53ef\u80fd\u6027\uff0c\u5982\u5fc3\u8840\u7ba1\u75be\u75c5\u3001\u9ad8\u8840\u538b\u3001\u4e2d\u98ce\u3001\u7cbe\u795e\u75be\u75c5\u751a\u81f3\u7cd6\u5c3f\u75c5\u3002 \u672a\u786e\u8bca\u7684\u7761\u7720\u547c\u5438\u6682\u505c\u6bcf\u5e74\u7ed9\u7f8e\u56fd\u4eba\u53e3\u9020\u6210\u7684\u7ecf\u6d4e\u8d1f\u62c5\u7ea6\u4e3a1496\u4ebf\u7f8e\u5143\uff0c\u5176\u4e2d\u751f\u4ea7\u529b\u635f\u5931\u4e3a869\u4ebf\u7f8e\u5143\uff0c\u673a\u52a8\u8f66\u4e8b\u6545\u4e3a262\u4ebf\u7f8e\u5143\uff0c\u5de5\u4f5c\u573a\u6240\u4e8b\u6545\u4e3a65\u4ebf\u7f8e\u5143\u3002 \u5728\u6fb3\u5927\u5229\u4e9a\uff0cDeloitte Access Economics\u4f30\u8ba1\uff0cOSA\u6bcf\u5e74\u9020\u6210\u7684\u76f4\u63a5\u7ecf\u6d4e\u6210\u672c\u8d85\u8fc7210\u4ebf\u6fb3\u5143\u3002 \u5e02\u573a\u673a\u4f1a \u76ee\u524d\u9488\u5bf9OSA\u60a3\u8005\u7684\u6807\u51c6\u6cbb\u7597\u9009\u62e9\u662f\u673a\u68b0CPAP(\u6301\u7eed\u6c14\u9053\u6b63\u538b)\u88c5\u7f6e\u3002\u7136\u800c\uff0c\u7531\u4e8e\u5728\u7761\u7720\u65f6\u5c06\u52a0\u538b\u7a7a\u6c14\u5438\u5165\u53e3\u8154\uff0c\u665a\u4e0a\u6234\u4e0a\u53e3\u7f69\u5c06\u5176\u9001\u5165\u53e3\u8154\uff0c\u4ece\u800c\u5bfc\u81f4\u4e0d\u9002\u548c\u5e7d\u95ed\u6050\u60e7\u75c7\uff0c\u56e0\u6b64\u60a3\u8005\u7684\u957f\u671f\u4f9d\u4ece\u6027\u975e\u5e38\u4f4e\u3002 Incannex\u6267\u884c\u8463\u4e8bJoel Latham\u8868\u793a\uff0c\u7531\u4e8e\u76ee\u524d\u5c1a\u65e0\u6ce8\u518c\u7684\u836f\u7269\u6cbb\u7597\uff0cIHL-42X\u5b58\u5728\u5de8\u5927\u7684\u5e02\u573a\u673a\u4f1a\u3002 \u4ed6\u8bf4:\u201c\u4e00\u79cd\u6210\u529f\u7684\u836f\u7269\u6cbb\u7597\u5c06\u662f\u963b\u585e\u6027\u7761\u7720\u547c\u5438\u6682\u505c\u7684\u5178\u8303\u8f6c\u53d8\uff0c\u4e5f\u662f\u5411\u4e0d\u80fd\u8010\u53d7CPAP\u88c5\u7f6e\u7684\u60a3\u8005\u7684\u6b63\u786e\u65b9\u5411\u8fc8\u51fa\u7684\u91cd\u8981\u4e00\u6b65\u3002\u201d \u201c\u6211\u4eec\u671f\u671b\u80fd\u6781\u5927\u5730\u6539\u5584\u60a3\u8005\u7684\u6cbb\u7597\u4f9d\u4ece\u6027\u548c\u836f\u7269\u4ea7\u54c1\u7684\u6548\u679c\uff0c\u5982\u679c\u4e34\u5e8a\u8bc4\u4f30\u6210\u529f\u7684\u8bdd\uff0c\u8fd9\u53ef\u80fd\u662fIHL-42X\u3002\u201d \u65b0\u4efb\u547d \u540c\u65f6\uff0c\u5728\u672c\u5468\u7684\u5468\u4e8c\uff0cIncannex\u5ba3\u5e03\u4efb\u547dPaul Liknaitzky\u535a\u58eb\u4e3a\u5176\u533b\u5b66\u987e\u95ee\u59d4\u5458\u4f1a\u7684\u79d1\u5b66\u5b98\u5458\uff0c\u4efb\u671f\u81f3\u5c11\u4e3a18\u4e2a\u6708\uff0c\u6709\u4e13\u6709\u6743\u3002 \u4ed6\u5c06\u4e3a\u65b0\u578b\u7cbe\u795e\u5236\u5242\u548c\u76f8\u5173\u7597\u6cd5\u7684\u7814\u7a76\u63d0\u4f9b\u5efa\u8bae\uff0c\u8fd9\u4e9b\u5236\u5242\u548c\u7597\u6cd5\u53ef\u80fd\u9002\u7528\u4e8e\u7126\u8651\u75c7\u548c\u6291\u90c1\u75c7\u76f8\u5173\u75be\u75c5\u7684\u6cbb\u7597\u3002 \u73b0\u6709\u7684\u6cbb\u7597\u7126\u8651\u548c\u6291\u90c1\u7684\u836f\u7269\u9009\u62e9\u88ab\u8ba4\u4e3a\u6ca1\u6709\u8db3\u591f\u7684\u53cd\u5e94\u7387\u548c\u76f8\u5173\u7684\u4e0d\u826f\u526f\u4f5c\u7528\u3002 Liknaitzky\u535a\u58eb\u5728\u58a8\u5c14\u672c\u5927\u5b66\u83b7\u5f97\u4e86\u795e\u7ecf\u79d1\u5b66\u8363\u8a89\u548c\u5fc3\u7406\u5b66\u535a\u58eb\u5b66\u4f4d\u3002\u4ed6\u7684\u5de5\u4f5c\u4e3b\u8981\u5728\u6291\u90c1\u3001\u7126\u8651\u548c\u6210\u763e\u7814\u7a76\u4e2d\u68c0\u67e5\u7cbe\u795e\u75be\u75c5\u7684\u673a\u5236\u548c\u6cbb\u7597\u53d1\u5c55\u3002 \u4ed6\u5728\u58a8\u5c14\u672c\u7684\u5723\u6587\u68ee\u7279\u533b\u9662\u548c\u5176\u4ed6\u673a\u6784\u4efb\u804c\uff0c\u53c2\u4e0e\u4e86\u8ff7\u5e7b\u836f\u8fd9\u4e00\u65b0\u5174\u9886\u57df\u7684\u7814\u7a76\u3002<\/p>\n","protected":false},"author":4,"featured_media":9465,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[33],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v17.3 (Yoast SEO v21.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Incannex\u57282b\u671f\u963b\u585e\u6027\u7761\u7720\u547c\u5438\u6682\u505c\u8bd5\u9a8c\u4e2d\u7684\u65b0\u578b\u5927\u9ebb\u7d20\u83b7\u5f97\u4f26\u7406\u6279\u51c6<\/title>\n<meta name=\"description\" content=\"Incannex Healthcare (ASX: IHL)\u5bf9\u5176\u5148\u5bfc\u836f\u7269IHL- 42x\u6cbb\u7597\u963b\u585e\u6027\u7761\u7720\u547c\u5438\u6682\u505c(OSA)\u60a3\u8005\u76842b\u671f\u4e34\u5e8a\u8bd5\u9a8c\u5df2\u83b7\u5f97\u4f26\u7406\u6279\u51c6\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Incannex\u57282b\u671f\u963b\u585e\u6027\u7761\u7720\u547c\u5438\u6682\u505c\u8bd5\u9a8c\u4e2d\u7684\u65b0\u578b\u5927\u9ebb\u7d20\u83b7\u5f97\u4f26\u7406\u6279\u51c6\" \/>\n<meta property=\"og:description\" content=\"Incannex Healthcare (ASX: IHL)\u5bf9\u5176\u5148\u5bfc\u836f\u7269IHL- 42x\u6cbb\u7597\u963b\u585e\u6027\u7761\u7720\u547c\u5438\u6682\u505c(OSA)\u60a3\u8005\u76842b\u671f\u4e34\u5e8a\u8bd5\u9a8c\u5df2\u83b7\u5f97\u4f26\u7406\u6279\u51c6\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/incannex-ethics-approval-cannabinoid-phase-2b-clinical-trial-obstructive-sleep-apnoea\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2020-09-24T01:05:03+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T17:47:03+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/09\/Incannex-Healthcare-IHL-ASX-cannabinoid-Obstructive-Sleep-Apnoea-clinical-trial.jpg\" \/>\n<meta name=\"author\" content=\"Imelda Cotton\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Incannex\u57282b\u671f\u963b\u585e\u6027\u7761\u7720\u547c\u5438\u6682\u505c\u8bd5\u9a8c\u4e2d\u7684\u65b0\u578b\u5927\u9ebb\u7d20\u83b7\u5f97\u4f26\u7406\u6279\u51c6\" \/>\n<meta name=\"twitter:description\" content=\"Incannex Healthcare (ASX: IHL)\u5bf9\u5176\u5148\u5bfc\u836f\u7269IHL- 42x\u6cbb\u7597\u963b\u585e\u6027\u7761\u7720\u547c\u5438\u6682\u505c(OSA)\u60a3\u8005\u76842b\u671f\u4e34\u5e8a\u8bd5\u9a8c\u5df2\u83b7\u5f97\u4f26\u7406\u6279\u51c6\u3002\" \/>\n<meta name=\"twitter:image\" content=\"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/09\/Incannex-Healthcare-IHL-ASX-cannabinoid-Obstructive-Sleep-Apnoea-clinical-trial.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Imelda Cotton\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/incannex-ethics-approval-cannabinoid-phase-2b-clinical-trial-obstructive-sleep-apnoea\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/incannex-ethics-approval-cannabinoid-phase-2b-clinical-trial-obstructive-sleep-apnoea\/\",\"name\":\"Incannex\u57282b\u671f\u963b\u585e\u6027\u7761\u7720\u547c\u5438\u6682\u505c\u8bd5\u9a8c\u4e2d\u7684\u65b0\u578b\u5927\u9ebb\u7d20\u83b7\u5f97\u4f26\u7406\u6279\u51c6\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2020-09-24T01:05:03+00:00\",\"dateModified\":\"2023-08-29T17:47:03+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e\"},\"description\":\"Incannex Healthcare (ASX: IHL)\u5bf9\u5176\u5148\u5bfc\u836f\u7269IHL- 42x\u6cbb\u7597\u963b\u585e\u6027\u7761\u7720\u547c\u5438\u6682\u505c(OSA)\u60a3\u8005\u76842b\u671f\u4e34\u5e8a\u8bd5\u9a8c\u5df2\u83b7\u5f97\u4f26\u7406\u6279\u51c6\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/incannex-ethics-approval-cannabinoid-phase-2b-clinical-trial-obstructive-sleep-apnoea\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/incannex-ethics-approval-cannabinoid-phase-2b-clinical-trial-obstructive-sleep-apnoea\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/incannex-ethics-approval-cannabinoid-phase-2b-clinical-trial-obstructive-sleep-apnoea\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Incannex\u57282b\u671f\u963b\u585e\u6027\u7761\u7720\u547c\u5438\u6682\u505c\u8bd5\u9a8c\u4e2d\u7684\u65b0\u578b\u5927\u9ebb\u7d20\u83b7\u5f97\u4f26\u7406\u6279\u51c6\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e\",\"name\":\"Imelda Cotton\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g\",\"caption\":\"Imelda Cotton\"},\"description\":\"Imelda Cotton has over 20 years experience as a journalist and communications professional. She has spent the bulk of her career in the resources sector, having also worked directly with oil and gas majors and as a journalist covering a vast array of ASX listed companies within the resources, energy, science and health sectors.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=4\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Incannex\u57282b\u671f\u963b\u585e\u6027\u7761\u7720\u547c\u5438\u6682\u505c\u8bd5\u9a8c\u4e2d\u7684\u65b0\u578b\u5927\u9ebb\u7d20\u83b7\u5f97\u4f26\u7406\u6279\u51c6","description":"Incannex Healthcare (ASX: IHL)\u5bf9\u5176\u5148\u5bfc\u836f\u7269IHL- 42x\u6cbb\u7597\u963b\u585e\u6027\u7761\u7720\u547c\u5438\u6682\u505c(OSA)\u60a3\u8005\u76842b\u671f\u4e34\u5e8a\u8bd5\u9a8c\u5df2\u83b7\u5f97\u4f26\u7406\u6279\u51c6\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Incannex\u57282b\u671f\u963b\u585e\u6027\u7761\u7720\u547c\u5438\u6682\u505c\u8bd5\u9a8c\u4e2d\u7684\u65b0\u578b\u5927\u9ebb\u7d20\u83b7\u5f97\u4f26\u7406\u6279\u51c6","og_description":"Incannex Healthcare (ASX: IHL)\u5bf9\u5176\u5148\u5bfc\u836f\u7269IHL- 42x\u6cbb\u7597\u963b\u585e\u6027\u7761\u7720\u547c\u5438\u6682\u505c(OSA)\u60a3\u8005\u76842b\u671f\u4e34\u5e8a\u8bd5\u9a8c\u5df2\u83b7\u5f97\u4f26\u7406\u6279\u51c6\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/incannex-ethics-approval-cannabinoid-phase-2b-clinical-trial-obstructive-sleep-apnoea\/","og_site_name":"smallcapsCN","article_published_time":"2020-09-24T01:05:03+00:00","article_modified_time":"2023-08-29T17:47:03+00:00","og_image":[{"url":"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/09\/Incannex-Healthcare-IHL-ASX-cannabinoid-Obstructive-Sleep-Apnoea-clinical-trial.jpg"}],"author":"Imelda Cotton","twitter_card":"summary_large_image","twitter_title":"Incannex\u57282b\u671f\u963b\u585e\u6027\u7761\u7720\u547c\u5438\u6682\u505c\u8bd5\u9a8c\u4e2d\u7684\u65b0\u578b\u5927\u9ebb\u7d20\u83b7\u5f97\u4f26\u7406\u6279\u51c6","twitter_description":"Incannex Healthcare (ASX: IHL)\u5bf9\u5176\u5148\u5bfc\u836f\u7269IHL- 42x\u6cbb\u7597\u963b\u585e\u6027\u7761\u7720\u547c\u5438\u6682\u505c(OSA)\u60a3\u8005\u76842b\u671f\u4e34\u5e8a\u8bd5\u9a8c\u5df2\u83b7\u5f97\u4f26\u7406\u6279\u51c6\u3002","twitter_image":"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/09\/Incannex-Healthcare-IHL-ASX-cannabinoid-Obstructive-Sleep-Apnoea-clinical-trial.jpg","twitter_misc":{"Written by":"Imelda Cotton"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/incannex-ethics-approval-cannabinoid-phase-2b-clinical-trial-obstructive-sleep-apnoea\/","url":"https:\/\/smallcapscn.x5view.co\/incannex-ethics-approval-cannabinoid-phase-2b-clinical-trial-obstructive-sleep-apnoea\/","name":"Incannex\u57282b\u671f\u963b\u585e\u6027\u7761\u7720\u547c\u5438\u6682\u505c\u8bd5\u9a8c\u4e2d\u7684\u65b0\u578b\u5927\u9ebb\u7d20\u83b7\u5f97\u4f26\u7406\u6279\u51c6","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2020-09-24T01:05:03+00:00","dateModified":"2023-08-29T17:47:03+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e"},"description":"Incannex Healthcare (ASX: IHL)\u5bf9\u5176\u5148\u5bfc\u836f\u7269IHL- 42x\u6cbb\u7597\u963b\u585e\u6027\u7761\u7720\u547c\u5438\u6682\u505c(OSA)\u60a3\u8005\u76842b\u671f\u4e34\u5e8a\u8bd5\u9a8c\u5df2\u83b7\u5f97\u4f26\u7406\u6279\u51c6\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/incannex-ethics-approval-cannabinoid-phase-2b-clinical-trial-obstructive-sleep-apnoea\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/incannex-ethics-approval-cannabinoid-phase-2b-clinical-trial-obstructive-sleep-apnoea\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/incannex-ethics-approval-cannabinoid-phase-2b-clinical-trial-obstructive-sleep-apnoea\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"Incannex\u57282b\u671f\u963b\u585e\u6027\u7761\u7720\u547c\u5438\u6682\u505c\u8bd5\u9a8c\u4e2d\u7684\u65b0\u578b\u5927\u9ebb\u7d20\u83b7\u5f97\u4f26\u7406\u6279\u51c6"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e","name":"Imelda Cotton","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g","caption":"Imelda Cotton"},"description":"Imelda Cotton has over 20 years experience as a journalist and communications professional. She has spent the bulk of her career in the resources sector, having also worked directly with oil and gas majors and as a journalist covering a vast array of ASX listed companies within the resources, energy, science and health sectors.","url":"https:\/\/smallcapscn.x5view.co\/?author=4"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/1984"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1984"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/1984\/revisions"}],"predecessor-version":[{"id":9464,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/1984\/revisions\/9464"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/9465"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1984"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1984"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1984"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}